| Estimating heterogeneous treatment effect of lung cancer in PLCO trial |
Yang Zhao |
Nanjing Medical University |
PLCO |
Nov 13, 2018 |
PLCO-424 |
| A systematic evaluation of environmental and genetic factors associated with incidence and mortality of prostate, lung, colorectal and ovarian cancer. |
Wendy Lam |
The University of Hong Kong |
PLCO |
Nov 13, 2018 |
PLCO-409 |
| Evaluating genetic, clinical, and environmental risk factors for second primary lung cancer |
Summer Han |
Stanford University |
PLCO |
Nov 13, 2018 |
PLCO-423 |
| Colonoscopy Adenoma Findings in Different Age Are Associated With Diverse Long-term Colorectal Cancer Incidence |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-420 |
| NSAID use and ovarian cancer risk of morbidity and survival |
Jieyu He |
Department of Biostatistics, School of Public Health, Nanjing Medical University |
PLCO |
Nov 7, 2018 |
PLCO-421 |
| Association Between Aspirin Use and Risk of Liver Carcinoma: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 4 cohort studies |
Xuesi Dong |
Nanjing Medical University |
PLCO |
Nov 5, 2018 |
PLCO-419 |
| Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project |
Danxia Yu |
Vanderbilt University Medical Center |
PLCO |
Nov 2, 2018 |
PLCO-414 |
| Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Nov 2, 2018 |
PLCO-417 |
| Future diagnosis prediction of lung cancer using convolutional and recurrent networks. |
Latifur Khan |
University of Texas at Dallas |
NLST |
Oct 31, 2018 |
NLST-449 |
| Long Term Outcomes in Active Smokers Undergoing Lung Resection: An Analysis of the National Lung Cancer Screening Trial |
Joanna Sesti |
Robert Wood Johnson Barnabas Health |
NLST |
Oct 26, 2018 |
NLST-448 |
| Lung Cancer Risk Prediction Modelling -- Extensions to the PLCOm2012 model |
Martin Carl Tammemagi |
Brock University |
PLCO |
Oct 26, 2018 |
PLCO-416 |
| Clinical Cancer Data Analysis |
Canan Eren |
New Jersey Institute of Technology |
PLCO |
Oct 26, 2018 |
PLCO-410 |
| Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jiaqi Huang |
NIH |
PLCO |
Oct 23, 2018 |
2017-1017 |
| Physical activity, PSA levels, and screen-detected prostate cancers. |
Yelena Tarasenko |
Georgia Southern University |
PLCO |
Oct 23, 2018 |
PLCO-415 |
| The role of environmental and socioeconomic factors in urologic malignancies |
Bashir Al Hussein |
New York Presbyterian Hospital |
NLST |
Oct 16, 2018 |
NLST-446 |
| The use of data from Food Frequency Questionnaire (FFQ) for network analysis on cancer survivorship and food intake |
Linghan Qian |
Tufts University |
PLCO |
Oct 15, 2018 |
PLCO-405 |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO |
Paramita Saha-Chaudhuri |
McGill University |
PLCO |
Oct 12, 2018 |
PLCO-408 |
| Impact of colorectal cancer sidedness on the outcomes of colorectal cancer patients diagnosed within PLCO study |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Oct 12, 2018 |
PLCO-407 |
| Outcomes of stage I non-small cell lung cancer patients treated with surgery versus radiation therapy within the NLST |
Omar Abdel-Rahman |
Avicenna Oncology center |
NLST |
Oct 11, 2018 |
NLST-445 |
| Diabetes and Cancer Initiative |
Marc Gunter |
International Agency for Research on Cancer |
PLCO |
Oct 11, 2018 |
PLCO-397 |
